Search

Your search keyword '"Thyssen, Jacob P"' showing total 385 results

Search Constraints

Start Over You searched for: Author "Thyssen, Jacob P" Remove constraint Author: "Thyssen, Jacob P" Database Complementary Index Remove constraint Database: Complementary Index
385 results on '"Thyssen, Jacob P"'

Search Results

2. Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment.

3. Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years: an analysis by sex and age.

4. Subclinical immune responses to nickel in sensitized individuals—a dose–response study.

5. RNA‐sequencing of paired tape‐strips and skin biopsies in atopic dermatitis reveals key differences.

6. Impact of climate change on atopic dermatitis: A review by the International Eczema Council.

8. Inflammatory plasma signature of chronic hand eczema: Associations with aetiological and clinical subtypes.

10. Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis.

11. Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).

13. Prevalence and incidence of hand eczema in healthcare workers: A systematic review and meta‐analysis.

14. Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.

15. The vIGA‐AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council.

17. Comorbidities in childhood atopic dermatitis: A population‐based study.

18. Atopic dermatitis phenotypes based on cluster analysis of the Danish Skin Cohort.

19. Attitudes towards clinical research in adult patients with hidradenitis suppurativa during the COVID-19 pandemic: Insights from a survey.

20. Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.

21. Treat-to-Target in Atopic Dermatitis.

22. Treat‐to‐target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis.

23. Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial.

26. No associations between type 1 diabetes and atopic dermatitis, allergic rhinitis, or asthma in childhood: a nationwide Danish case-cohort study.

28. Limited clinical role of blood eosinophil levels in early life atopic disease: A mother–child cohort study.

29. A Skin Care Program to Prevent Skin Problems due to Diabetes Devices in Children and Adolescents: A Cluster-Controlled Intervention Study.

30. A detailed look at the European Medicines Agency's recommendations for use of Janus kinase inhibitors in patients with atopic dermatitis.

32. The Association Between Fatigue and Adult Atopic Dermatitis: A Cross-Sectional Study.

33. Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis.

34. Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16.

35. 651 - Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis.

36. Prevalence of ichthyoses in Denmark: a nationwide registry-based study.

37. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.

38. Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials.

39. Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey.

40. Treatment with delgocitinib cream improves itch, pain and other signs and symptoms of chronic hand eczema: Results from the Hand Eczema Symptom Diary in a phase IIb randomized clinical trial.

41. Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis.

42. Association of homelessness and skin conditions: a Danish population-based cohort study.

43. Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials.

44. Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials.

45. Adverse reactions after oral provocation with aluminium in children with vaccination granulomas and aluminium contact allergy.

46. Prevalence and risk factors for atopic dermatitis in Greenlandic children.

47. Short-term real-world experience with baricitinib treatment in Danish adults with moderate–severe atopic dermatitis.

48. Access to psoriasis treatment in Brazil and Chile: A cross-sectional multicentre Global Healthcare Study on Psoriasis.

49. Skin biomarkers predict development of atopic dermatitis in infancy.

50. Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severity.

Catalog

Books, media, physical & digital resources